he vaccine model of health care has taken another nose five as
researchers report that since 2000, when Wyeth's bacterial strep vaccine Prevnar was put on the market, drug-resistant and rapidly mutating bacteria have moved in to fill the void left by those bacteria treated with the vaccine. While Wyeth sold $1.5 billion of its vaccine last year....
Read More: antibiotics,
bacterial strep vaccine,
immunizations,
Prevnar,
Wyeth